| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Muscle Neoplasms | 1 | 2019 | 14 | 0.81 | Why? |
| Radiation Dosage | 3 | 2021 | 585 | 0.80 | Why? |
| Meglumine | 1 | 2018 | 26 | 0.74 | Why? |
| Polycystic Kidney Diseases | 1 | 2017 | 6 | 0.72 | Why? |
| Antidiuretic Hormone Receptor Antagonists | 1 | 2017 | 18 | 0.71 | Why? |
| Radiology Information Systems | 1 | 2018 | 72 | 0.70 | Why? |
| Benzazepines | 1 | 2017 | 49 | 0.68 | Why? |
| Body Composition | 1 | 2020 | 414 | 0.64 | Why? |
| Image Enhancement | 1 | 2018 | 177 | 0.63 | Why? |
| Cysts | 1 | 2017 | 94 | 0.62 | Why? |
| Organometallic Compounds | 1 | 2018 | 206 | 0.59 | Why? |
| Documentation | 1 | 2018 | 332 | 0.58 | Why? |
| Research Report | 1 | 2018 | 376 | 0.54 | Why? |
| Tomography, X-Ray Computed | 12 | 2020 | 25144 | 0.51 | Why? |
| Respiration | 1 | 2018 | 729 | 0.48 | Why? |
| Contrast Media | 2 | 2018 | 1011 | 0.48 | Why? |
| Muscle, Skeletal | 1 | 2019 | 915 | 0.47 | Why? |
| Image Interpretation, Computer-Assisted | 2 | 2018 | 665 | 0.47 | Why? |
| Thorax | 2 | 2020 | 1873 | 0.45 | Why? |
| Magnetic Resonance Imaging | 4 | 2020 | 6551 | 0.39 | Why? |
| Ataxia Telangiectasia Mutated Proteins | 2 | 2019 | 48 | 0.38 | Why? |
| Neoplasms, Experimental | 2 | 2019 | 67 | 0.35 | Why? |
| Tumor Suppressor Protein p53 | 3 | 2018 | 310 | 0.33 | Why? |
| Liver | 2 | 2020 | 4007 | 0.33 | Why? |
| Kidney | 2 | 2019 | 3648 | 0.32 | Why? |
| Leukemia, Lymphocytic, Chronic, B-Cell | 3 | 2020 | 877 | 0.32 | Why? |
| Drug Resistance, Neoplasm | 3 | 2018 | 447 | 0.31 | Why? |
| Pulmonary Aspergillosis | 2 | 2020 | 408 | 0.29 | Why? |
| Radiography, Dual-Energy Scanned Projection | 2 | 2019 | 53 | 0.23 | Why? |
| Proto-Oncogene Proteins p21(ras) | 2 | 2019 | 100 | 0.22 | Why? |
| Radiographic Image Interpretation, Computer-Assisted | 2 | 2019 | 869 | 0.22 | Why? |
| Checkpoint Kinase 1 | 1 | 2019 | 10 | 0.21 | Why? |
| Paramyxoviridae Infections | 2 | 2020 | 364 | 0.21 | Why? |
| Fluorine Radioisotopes | 1 | 2019 | 59 | 0.20 | Why? |
| Glucose Transporter Type 1 | 1 | 2019 | 30 | 0.20 | Why? |
| ErbB Receptors | 2 | 2018 | 320 | 0.20 | Why? |
| Obesity | 1 | 2020 | 7388 | 0.20 | Why? |
| Artifacts | 2 | 2018 | 250 | 0.19 | Why? |
| Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2018 | 28 | 0.19 | Why? |
| Celiac Artery | 1 | 2018 | 13 | 0.19 | Why? |
| Erlotinib Hydrochloride | 1 | 2018 | 48 | 0.19 | Why? |
| Tyrosine | 1 | 2018 | 66 | 0.19 | Why? |
| Iodine Radioisotopes | 1 | 2019 | 124 | 0.19 | Why? |
| Mesenteric Artery, Superior | 1 | 2018 | 29 | 0.19 | Why? |
| Calcinosis | 1 | 2021 | 240 | 0.18 | Why? |
| Cell Transformation, Neoplastic | 2 | 2018 | 191 | 0.18 | Why? |
| Proto-Oncogene Proteins c-met | 1 | 2017 | 40 | 0.18 | Why? |
| Infusions, Intraosseous | 1 | 2018 | 36 | 0.18 | Why? |
| Aorta, Thoracic | 1 | 2020 | 271 | 0.18 | Why? |
| NIMA-Related Kinases | 1 | 2017 | 9 | 0.18 | Why? |
| Niacinamide | 1 | 2019 | 135 | 0.18 | Why? |
| Protein Kinase Inhibitors | 2 | 2018 | 1585 | 0.18 | Why? |
| Bridged Bicyclo Compounds, Heterocyclic | 1 | 2018 | 77 | 0.17 | Why? |
| Bone Density | 1 | 2020 | 335 | 0.17 | Why? |
| Constriction, Pathologic | 1 | 2018 | 212 | 0.17 | Why? |
| Poly (ADP-Ribose) Polymerase-1 | 1 | 2017 | 76 | 0.17 | Why? |
| Injections, Intravenous | 1 | 2018 | 381 | 0.16 | Why? |
| Lumbar Vertebrae | 1 | 2018 | 196 | 0.16 | Why? |
| Apoptosis Regulatory Proteins | 1 | 2018 | 202 | 0.16 | Why? |
| Feasibility Studies | 3 | 2020 | 3467 | 0.16 | Why? |
| Repressor Proteins | 1 | 2018 | 232 | 0.15 | Why? |
| Myeloid Differentiation Factor 88 | 1 | 2016 | 109 | 0.15 | Why? |
| Mice, Transgenic | 3 | 2018 | 2739 | 0.15 | Why? |
| Neck | 1 | 2018 | 307 | 0.15 | Why? |
| Oligopeptides | 1 | 2019 | 576 | 0.15 | Why? |
| Piperazines | 1 | 2018 | 445 | 0.15 | Why? |
| Radiography, Thoracic | 3 | 2021 | 5486 | 0.15 | Why? |
| Lung | 3 | 2020 | 31049 | 0.15 | Why? |
| Observer Variation | 1 | 2018 | 622 | 0.15 | Why? |
| Image Processing, Computer-Assisted | 3 | 2021 | 1383 | 0.14 | Why? |
| Diffusion Magnetic Resonance Imaging | 1 | 2017 | 317 | 0.14 | Why? |
| Proof of Concept Study | 1 | 2017 | 696 | 0.14 | Why? |
| Mice, Inbred C57BL | 4 | 2018 | 5542 | 0.14 | Why? |
| Urologic Neoplasms | 1 | 2019 | 348 | 0.14 | Why? |
| Molecular Targeted Therapy | 3 | 2019 | 1579 | 0.14 | Why? |
| Radiopharmaceuticals | 1 | 2019 | 763 | 0.13 | Why? |
| Lymphoma, Large B-Cell, Diffuse | 1 | 2016 | 176 | 0.13 | Why? |
| Signal-To-Noise Ratio | 3 | 2019 | 217 | 0.13 | Why? |
| Apoptosis | 3 | 2019 | 2335 | 0.13 | Why? |
| Quality Assurance, Health Care | 1 | 2018 | 596 | 0.13 | Why? |
| Antifungal Agents | 2 | 2020 | 1828 | 0.12 | Why? |
| Resuscitation | 1 | 2018 | 638 | 0.12 | Why? |
| Germany | 4 | 2020 | 9196 | 0.11 | Why? |
| Brain Neoplasms | 1 | 2018 | 669 | 0.11 | Why? |
| Mouth Neoplasms | 1 | 2018 | 463 | 0.11 | Why? |
| Intersectoral Collaboration | 1 | 2018 | 1065 | 0.11 | Why? |
| Lymph Nodes | 1 | 2018 | 1060 | 0.11 | Why? |
| Lung Neoplasms | 2 | 2018 | 3228 | 0.11 | Why? |
| Neoplasm Recurrence, Local | 1 | 2018 | 1063 | 0.11 | Why? |
| Interdisciplinary Communication | 1 | 2018 | 1425 | 0.10 | Why? |
| Coinfection | 2 | 2020 | 6820 | 0.10 | Why? |
| Mutation, Missense | 1 | 2016 | 863 | 0.10 | Why? |
| Cell Proliferation | 1 | 2018 | 1973 | 0.10 | Why? |
| Mice | 6 | 2019 | 21357 | 0.10 | Why? |
| Positron Emission Tomography Computed Tomography | 1 | 2019 | 1458 | 0.10 | Why? |
| Male | 20 | 2021 | 367725 | 0.10 | Why? |
| Carcinoma, Non-Small-Cell Lung | 1 | 2018 | 896 | 0.10 | Why? |
| Carcinoma, Squamous Cell | 1 | 2018 | 902 | 0.10 | Why? |
| Fatigue | 1 | 2020 | 2479 | 0.10 | Why? |
| Disease Models, Animal | 2 | 2017 | 10998 | 0.09 | Why? |
| Sulfonamides | 1 | 2018 | 1294 | 0.09 | Why? |
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2019 | 1573 | 0.09 | Why? |
| Voriconazole | 2 | 2020 | 206 | 0.09 | Why? |
| Female | 19 | 2021 | 380317 | 0.09 | Why? |
| Middle Aged | 15 | 2021 | 270681 | 0.09 | Why? |
| Pilot Projects | 1 | 2020 | 5182 | 0.09 | Why? |
| Mice, Nude | 2 | 2019 | 340 | 0.09 | Why? |
| Early Diagnosis | 1 | 2017 | 2443 | 0.09 | Why? |
| Embryo, Mammalian | 2 | 2018 | 86 | 0.09 | Why? |
| Mutation | 5 | 2019 | 12376 | 0.08 | Why? |
| Prostatic Neoplasms | 1 | 2019 | 1637 | 0.08 | Why? |
| Coronary Artery Disease | 1 | 2021 | 2570 | 0.08 | Why? |
| Humans | 29 | 2021 | 930598 | 0.08 | Why? |
| Triazoles | 2 | 2020 | 440 | 0.08 | Why? |
| Nitriles | 2 | 2020 | 1053 | 0.07 | Why? |
| Predictive Value of Tests | 1 | 2020 | 9537 | 0.07 | Why? |
| Disease Progression | 2 | 2021 | 13580 | 0.07 | Why? |
| Intubation, Intratracheal | 1 | 2020 | 3962 | 0.07 | Why? |
| Prognosis | 4 | 2021 | 32490 | 0.07 | Why? |
| Pyridines | 2 | 2020 | 680 | 0.07 | Why? |
| Patient Admission | 1 | 2020 | 5250 | 0.07 | Why? |
| Liver Diseases | 1 | 2018 | 2698 | 0.06 | Why? |
| Adult | 9 | 2020 | 244371 | 0.06 | Why? |
| Antineoplastic Agents | 1 | 2018 | 3550 | 0.06 | Why? |
| Mice, Knockout | 2 | 2018 | 1815 | 0.06 | Why? |
| Pneumonia, Viral | 5 | 2020 | 243684 | 0.06 | Why? |
| Longitudinal Studies | 1 | 2017 | 9893 | 0.06 | Why? |
| Coronavirus Infections | 5 | 2020 | 253789 | 0.06 | Why? |
| Animals | 7 | 2019 | 78931 | 0.05 | Why? |
| IgG Deficiency | 1 | 2020 | 22 | 0.05 | Why? |
| B-Lymphocytes | 1 | 2016 | 4418 | 0.05 | Why? |
| Phantoms, Imaging | 1 | 2020 | 146 | 0.05 | Why? |
| Benzodiazepinones | 1 | 2019 | 4 | 0.05 | Why? |
| Hydroxybenzoates | 1 | 2019 | 25 | 0.05 | Why? |
| Cell Line, Tumor | 2 | 2019 | 3608 | 0.05 | Why? |
| Societies | 1 | 2020 | 95 | 0.05 | Why? |
| Galactose | 1 | 2020 | 201 | 0.05 | Why? |
| Aged | 8 | 2020 | 215776 | 0.05 | Why? |
| Drug Screening Assays, Antitumor | 1 | 2019 | 138 | 0.05 | Why? |
| Urothelium | 1 | 2019 | 34 | 0.05 | Why? |
| Cytoprotection | 1 | 2018 | 44 | 0.05 | Why? |
| Amphotericin B | 1 | 2020 | 256 | 0.05 | Why? |
| Acrylamides | 1 | 2018 | 40 | 0.05 | Why? |
| Shear Strength | 1 | 2018 | 17 | 0.05 | Why? |
| Motion | 1 | 2018 | 63 | 0.05 | Why? |
| Whole Body Imaging | 1 | 2019 | 116 | 0.05 | Why? |
| Azoles | 1 | 2020 | 185 | 0.05 | Why? |
| NIH 3T3 Cells | 1 | 2018 | 147 | 0.05 | Why? |
| Cyclin-Dependent Kinase Inhibitor p15 | 1 | 2018 | 10 | 0.05 | Why? |
| Cyclin-Dependent Kinase Inhibitor p18 | 1 | 2018 | 13 | 0.05 | Why? |
| Gene Dosage | 1 | 2018 | 101 | 0.05 | Why? |
| Xenograft Model Antitumor Assays | 1 | 2019 | 274 | 0.05 | Why? |
| Mannans | 1 | 2020 | 218 | 0.05 | Why? |
| Gene Duplication | 1 | 2017 | 31 | 0.05 | Why? |
| Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2018 | 45 | 0.05 | Why? |
| Aniline Compounds | 1 | 2018 | 120 | 0.05 | Why? |
| Cell Cycle Checkpoints | 1 | 2018 | 126 | 0.05 | Why? |
| Aorta, Abdominal | 1 | 2018 | 50 | 0.05 | Why? |
| Quinazolines | 1 | 2019 | 126 | 0.05 | Why? |
| Chromosomes, Human, Pair 17 | 1 | 2017 | 13 | 0.04 | Why? |
| Stress, Mechanical | 1 | 2018 | 143 | 0.04 | Why? |
| Chromosomes, Human, Pair 11 | 1 | 2017 | 16 | 0.04 | Why? |
| Gene Rearrangement | 1 | 2017 | 84 | 0.04 | Why? |
| Oncogene Proteins, Fusion | 1 | 2017 | 52 | 0.04 | Why? |
| Tissue Distribution | 1 | 2019 | 483 | 0.04 | Why? |
| Tibia | 1 | 2018 | 72 | 0.04 | Why? |
| Neck Dissection | 1 | 2018 | 109 | 0.04 | Why? |
| Chromosome Deletion | 1 | 2017 | 62 | 0.04 | Why? |
| Metapneumovirus | 1 | 2020 | 465 | 0.04 | Why? |
| Blood Flow Velocity | 1 | 2018 | 193 | 0.04 | Why? |
| Immunoblotting | 1 | 2017 | 180 | 0.04 | Why? |
| Critical Care | 1 | 2020 | 14081 | 0.04 | Why? |
| Sensitivity and Specificity | 1 | 2018 | 22971 | 0.04 | Why? |
| Epithelium | 1 | 2018 | 330 | 0.04 | Why? |
| Carcinogenesis | 1 | 2018 | 236 | 0.04 | Why? |
| DNA Damage | 1 | 2018 | 285 | 0.04 | Why? |
| Poly(ADP-ribose) Polymerase Inhibitors | 1 | 2017 | 121 | 0.04 | Why? |
| Drug Synergism | 1 | 2019 | 833 | 0.04 | Why? |
| Microsurgery | 1 | 2018 | 166 | 0.04 | Why? |
| Incidental Findings | 1 | 2020 | 487 | 0.04 | Why? |
| Reference Values | 1 | 2018 | 795 | 0.04 | Why? |
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2016 | 127 | 0.04 | Why? |
| Lymphatic Metastasis | 1 | 2018 | 537 | 0.04 | Why? |
| Chemoradiotherapy | 1 | 2018 | 362 | 0.04 | Why? |
| Cyclophosphamide | 1 | 2017 | 387 | 0.04 | Why? |
| Awareness | 1 | 2020 | 529 | 0.04 | Why? |
| Regeneration | 1 | 2018 | 429 | 0.04 | Why? |
| Neoadjuvant Therapy | 1 | 2018 | 554 | 0.03 | Why? |
| Biomarkers | 1 | 2018 | 23361 | 0.03 | Why? |
| Ligands | 1 | 2019 | 1300 | 0.03 | Why? |
| Treatment Outcome | 2 | 2020 | 51732 | 0.03 | Why? |
| Fibroblasts | 1 | 2018 | 839 | 0.03 | Why? |
| Pleural Effusion | 1 | 2020 | 680 | 0.03 | Why? |
| Cadaver | 1 | 2018 | 626 | 0.03 | Why? |
| Radiologists | 1 | 2020 | 873 | 0.03 | Why? |
| Time Factors | 1 | 2017 | 31397 | 0.03 | Why? |
| Risk Factors | 2 | 2020 | 71621 | 0.03 | Why? |
| Stillbirth | 1 | 2018 | 544 | 0.03 | Why? |
| Imaging, Three-Dimensional | 1 | 2018 | 680 | 0.03 | Why? |
| Regression Analysis | 1 | 2020 | 2484 | 0.03 | Why? |
| Positron-Emission Tomography | 1 | 2018 | 802 | 0.03 | Why? |
| Infant, Premature | 1 | 2018 | 883 | 0.03 | Why? |
| Neoplasm Proteins | 1 | 2018 | 501 | 0.03 | Why? |
| Gestational Age | 1 | 2018 | 1488 | 0.03 | Why? |
| Young Adult | 3 | 2018 | 93724 | 0.03 | Why? |
| Hospitals, Teaching | 1 | 2020 | 1609 | 0.03 | Why? |
| Protein Binding | 2 | 2018 | 11430 | 0.03 | Why? |
| Linear Models | 1 | 2018 | 1914 | 0.03 | Why? |
| Bronchoalveolar Lavage Fluid | 1 | 2020 | 2309 | 0.03 | Why? |
| Pandemics | 8 | 2021 | 389249 | 0.03 | Why? |
| Neoplasm Staging | 1 | 2017 | 1999 | 0.03 | Why? |
| Protein Interaction Domains and Motifs | 1 | 2017 | 2134 | 0.03 | Why? |
| Kinetics | 1 | 2018 | 3238 | 0.03 | Why? |
| Immunohistochemistry | 1 | 2017 | 2275 | 0.03 | Why? |
| Hemodynamics | 1 | 2018 | 1562 | 0.02 | Why? |
| Hospitalization | 1 | 2020 | 54280 | 0.02 | Why? |
| Biopsy | 1 | 2018 | 2811 | 0.02 | Why? |
| Recurrence | 1 | 2019 | 3675 | 0.02 | Why? |
| Prospective Studies | 3 | 2018 | 43301 | 0.02 | Why? |
| Radiology | 1 | 2020 | 1199 | 0.02 | Why? |
| Pyrazoles | 1 | 2019 | 1791 | 0.02 | Why? |
| Cost-Benefit Analysis | 1 | 2018 | 2259 | 0.02 | Why? |
| Immunoglobulins, Intravenous | 1 | 2020 | 2705 | 0.02 | Why? |
| Stroke Volume | 1 | 2018 | 2153 | 0.02 | Why? |
| Betacoronavirus | 3 | 2020 | 204454 | 0.02 | Why? |
| Hemorrhage | 1 | 2020 | 3013 | 0.02 | Why? |
| Protein Conformation | 1 | 2018 | 4386 | 0.02 | Why? |
| Retrospective Studies | 4 | 2020 | 105322 | 0.02 | Why? |
| Outpatients | 1 | 2020 | 3417 | 0.02 | Why? |
| Multivariate Analysis | 1 | 2018 | 5440 | 0.02 | Why? |
| Cells, Cultured | 1 | 2018 | 5835 | 0.02 | Why? |
| Lung Diseases | 1 | 2020 | 2361 | 0.02 | Why? |
| Gene Expression Profiling | 1 | 2017 | 3788 | 0.02 | Why? |
| Polymerase Chain Reaction | 1 | 2020 | 6740 | 0.02 | Why? |
| Survival Analysis | 1 | 2017 | 7592 | 0.02 | Why? |
| Ambulatory Care | 1 | 2020 | 4947 | 0.02 | Why? |
| Inflammation | 1 | 2020 | 13255 | 0.01 | Why? |
| Aged, 80 and over | 2 | 2018 | 88759 | 0.01 | Why? |
| Infant, Newborn | 1 | 2018 | 23105 | 0.01 | Why? |
| Intensive Care Units | 1 | 2020 | 29594 | 0.01 | Why? |
| Cross-Sectional Studies | 1 | 2018 | 53120 | 0.01 | Why? |
| Spike Glycoprotein, Coronavirus | 1 | 2020 | 37182 | 0.01 | Why? |
| Antibodies, Viral | 1 | 2020 | 51949 | 0.01 | Why? |